Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Cell Scattering Activity of Natural Plant Extracts

자생식물 추출물의 세포 분산 활성

  • Cho, Min-Kyung (Department of microbiology, College of Medicine, Dankook University) ;
  • Kim, Young-Jae (Department of Microbiology, College of National Sciences, Changwon National University) ;
  • Shin, Deug-Y (Department of microbiology, College of Medicine, Dankook University) ;
  • Choi, Tae-Saeng (Department of microbiology, College of Medicine, Dankook University)
  • 조민경 (단국대학교 의과대학교 미생물학교실) ;
  • 김영재 (창원대학교 자연과학대학) ;
  • 신득용 (단국대학교 의과대학교 미생물학교실) ;
  • 최태생 (단국대학교 의과대학교 미생물학교실)
  • Published : 2004.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Cell-scattering is a phenotypic change easily observed in most epithelial cells treated with Hepatocyte Growth Factor /scatter Factor (HGF/SF) or phorbol esters (PKC-activators). Recent studies have shown the possibilities to use as therapeutic materials of HGF/SF or non tumor promoting phorbol esters for liver disease, cancer and AIDS. In this study, we tested a cell-scattering activity of 534 methanol extracts from plants inhabiting in Korean peninsula using the phenotype-based assay system. Nine Active extracts were detected : Daphne genkwa, Daphne kiusiana, and Aleurites fordii showed high activity (+++), Euphorbia sieboldiana and Rhodotypos scandens showed medium activity (++), Sambucus sieboldiana var. pendula, Catalpa bignonioides, Sambucus sieboldiana and Lycoris squamigera showed low activity (+). Furthermore, the effects of these active materials in the culture cells were investigated with biochemical studies.

Keywords

References

  1. Tamagnone, L. and Comoglio P. M. (1997) Control ofinvasive growth by Hepatocyte Growth Factor (HGF) andrelated scatter factor. Cytokine Growth Factor Rev. 6: 129-142
  2. Wen Jiang, Stephen Hiscox, Kunio Matsumoto, andToshikazu Nakamura (1999) Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implicationsin cancer. Oncology Hematology. 29: 209-248
  3. Jeffers, M., Rong, S., and Vande Woude, G. F. (1996)Hepatocyte growth factor/scatter factor-Met signaling intumorigenicity and invasion/metastasis. J. Mol. Med. 74:505-513 https://doi.org/10.1007/BF00204976
  4. Stracke, M. L. and Liotta, L. A. In: Mendelson J. HowleyPM. Israel MA. Liotta LA, editors (1995) The MolecularBasis of Cancer. Philadelphia, PA: Saunders. 233-47
  5. Joang, W. G. Puntis, M. C. A., and Hallett, M. B. (1994) Themolecular and cellular basis of cancer invasion andmetastasis and its implications for treatment. Br. J. Sura. 81:1576-90 https://doi.org/10.1002/bjs.1800811107
  6. Susumu Tanimura, Yuji Chatani, Rika Hoshino, MasahiroSato, Shin-ichi Watanabe, Tadashi Kataoka, ToshikazuNakamura, and Michiaki Kohno (1998) Activation of 41/43kDa mitogen-activated protein kinase signaling pathway isrequired for hepatocyte growth factor-induced cell scattering.Oncogene. 17: 57-65 https://doi.org/10.1038/sj.onc.1201905
  7. Donate, L. E., Gherardi, E., Srinivasan, N. et al. (1994)Molecular evolution and domain-structure of Plasminogen-related growth factor(HGF/SF and HGFl/MSP). Protein Sci.3: 2278-94
  8. Ponzetto, C., Bardelli, A., and Zhen, Z. et al. (1994) Amultifuctional docking site mediates signaling andtransformation by the hepatocyte growth factor scatter factor-recetor family. Cell. 77: 261-71 https://doi.org/10.1016/0092-8674(94)90318-2
  9. Ponzetto, C., Bardelli, A., and Maina, F. et al. (1993) ANovel recognition motif for phosphatidylinositol 3-kinasebinding mediates its association with the hepatocyte growthfactor scatter factor-recetor. Mol. Cell Biol. 13: 4600-8 https://doi.org/10.1128/MCB.13.8.4600
  10. Pawson, T. and Gish, C. D. (1992) SH2 and SH3 domains:from structure to function. Cell. 71: 359-62 https://doi.org/10.1016/0092-8674(92)90504-6
  11. Szabolcs Sipeki, Erzsebet Bander, Laszlo buday, Gyongyi Farkas, Erno Bacsy, D. Kirk Ways, and Anna Fargo (1999)Phophatidylinositol 3-kinase Contributes to Erk1/Erk2 MAPKinase Activation Associated with Hepatocyte GrowthFactor-induced Cell Scattering. Celt Signal. 12: 885-90
  12. Shigeo Ohno, Yoshiko Akita, Akiko Hata, Shin-Ichi Osada,Kyoko Kubo, Yasuhiko Konno, Kazunori Akimoto, KeikoMizuno, Takaomi Saido, Toshio Kuroki, and Koichi Suzuki(1991) Structural and fuctional diversities of a family ofsignal transduciong protien kinases, protein kinase c famliy ;Two distinct classes of PKC, conventional cPKC and NovelnPKC. Adv. Enzyme Requl. 31: 287-303 https://doi.org/10.1016/0065-2571(91)90018-H
  13. T. Ueki, Y. Kaneda, H. Tsutui, K. Nakanishi, Y. Sawa, R.Morishita, K. Matsumoto, T. Nakamura, H. Takhashi, and E.Okamoto, et al. (1999) Hepatocyte growth factor genetherapy of liver cirrhosis in rats, Nature Medicine. 5: 226-230 https://doi.org/10.1038/5593
  14. M. Tahara, K. Matsumoto, and T. Nakamura (1999) Hepa-tocyte growth factor leads to recovery from alcohol-inducedfat liver in rats. Journal of Clinical Investigation. 103: 313-326 https://doi.org/10.1172/JCI4433
  15. Inoue, M., Kishimoto, A., Taki, Y., and Nishizuka, Y. (1997)J. Biol. Chem. 252: 7610-7616
  16. Castagna, M. (1987) Phorbol ester as signal transducers andtumor promoter. Biol Cell. 59: 3-14 https://doi.org/10.1111/j.1768-322X.1987.tb00513.x
  17. Al-katib, A., Nohammed, R. M., Dan, M. et al. (1993)Bryostatin 1-induced hairy cell features on chroniclymphocytic leukemia cell in vitro. Exp. Hematol. 21: 61-5
  18. The Ethnobotanical Approach to Drug Discovery-CIBAFoundation Symposium 185 p. 25-41
  19. Yasuda, G., Imai, E., Shiota, A., Fujise, N., Morinage, T, andHigashio, K. (1996) Antifibrogenic effectof a deletion variantof hepatocyte growth factor on liver fibrosis in rats.Hepatology. 24: 636-642 https://doi.org/10.1002/hep.510240328
  20. Matsuda, Y., matsumoto, K., Nagata, S., Tsujimoto, Y., andNakamura, T. (1998) Abrogation of Fas-induced fulminathepatc failure in mice by hepatocytr growth factor. Biochem.Biophys Res. Commun. 1244: 683-690
  21. Saraiva, L., Fresco, P., Pinto, E., Portugal, H., and Goncalves,J. (2001) Differential activation by daphnetocyn and mezereinof PKC-isotypes alpha, beta I, delta and zeta. Planta Med.67: 787-90 https://doi.org/10.1055/s-2001-18843
  22. Driedger, P. E., Stabel, S., Frith, D., and Horgan, T. J. (1994)Mezerein and 12-deoxyphorbo1 13-isobutyrate, Proteinkinase C ligands with differential biological activities, do notdistinguish PKC-isotypes alpha, beta 1, beta 2, and gamma.Receptors Channels. 2: 99-106